Infection and Lupus: Which Causes Which?
Authors:
- 7 March 2016
- journal article
- review article
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 18 (3) , 1-9
Abstract
Infection is a leading cause of morbidity and mortality among patients with systemic lupus erythematous (SLE). Dysfunction of the innate and adaptive immune systems increases the risk of infection in patients with SLE. Infectious agents have also been theorized to play a role in the pathogenesis of SLE. This article summarizes our current knowledge of the infectious risk SLE patients face as a result of their underlying disease including abnormal phagocytes and T cells as well as the increased risk of infection associated with immunosuppressive agents used to treat disease. Pathogens thought to play a role in the pathogenesis of disease including EBV, CMV, human endogenous retroviruses (HERVs), and tuberculosis will also be reviewed, as well as the pathologic potential of microbial amyloids and the microbiome.Keywords
This publication has 108 references indexed in Scilit:
- Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosusArthritis Research & Therapy, 2014
- Rates of Serious Intracellular Infections in Autoimmune Disease Patients Receiving Initial Glucocorticoid TherapyPLOS ONE, 2013
- Human Endogenous Retroviruses (HERVs) and Autoimmune Rheumatic Disease: Is There a Link?The Open Rheumatology Journal, 2013
- Epstein-Barr Virus and Systemic Lupus ErythematosusJournal of Immunology Research, 2012
- Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-labelArthritis Research & Therapy, 2011
- The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case–control studyAnnals of the Rheumatic Diseases, 2011
- Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis TrialAnnals of the Rheumatic Diseases, 2010
- Epstein-Barr virus (EBV)–encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3Journal of Experimental Medicine, 2009
- Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activityTransplant Infectious Disease, 2009
- Predictors of major infections in systemic lupus erythematosusArthritis Research & Therapy, 2009